Literature DB >> 18242617

The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors.

Faisel Khan1, Jacob George, Kenneth Wong, Stephen McSwiggan, Allan D Struthers, Jill J F Belch.   

Abstract

There is increasing evidence that serum uric acid is an independent marker of cardiovascular risk. We have shown previously that high urate is associated with cardiac death in stroke survivors independently of conventional risk factors. We sought to determine in stroke survivors the association between high urate levels and arterial stiffness and endothelial function. One hundred and twenty stroke survivors were recruited. We assessed pulse wave velocity of the carotid artery using an echotracking ultrasound system. Endothelial function was assessed by measuring forearm skin blood flow responses, using laser Doppler imaging, to iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP). Patients with high serum urate (0.42-0.71 mmol/l) had a greater pulse wave velocity (P<0.02) and a lower ACh response (P=0.001) than patients with lower urate (0.12-0.28 mmol/l). Pulse wave velocity significantly correlated with serum urate (r=-0.358, P<0.001), HDL cholesterol (r=-0.22, P=0.02), and male gender (r=0.26, P=0.005). The ACh response significantly correlated with serum urate (r=-0.30, P=0.001), male gender (r=-0.45, P<0.001), HDL cholesterol (r=0.42, P<0.001), and triglycerides (r=-0.24, P=0.01). Stepwise multiple regression showed that serum urate was significantly associated with pulse wave velocity (beta=0.35, P<0.001), independently of other risk variables. For the ACh response the significant determinants were male gender (beta=-0.38, P<0.001) and HDL cholesterol (beta=0.23, P=0.018). We have shown for the first time that elevated serum urate is associated with increased arterial stiffness in stroke survivors, independently of other risk factors. A therapeutic intervention trial of lowering of serum urate is required to see whether this will impact positively on mortality and morbidity in patients with high-risk of strokes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242617     DOI: 10.1016/j.atherosclerosis.2007.12.023

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Genotype-based changes in serum uric acid affect blood pressure.

Authors:  Afshin Parsa; Eric Brown; Matthew R Weir; Jeffrey C Fink; Alan R Shuldiner; Braxton D Mitchell; Patrick F McArdle
Journal:  Kidney Int       Date:  2011-12-21       Impact factor: 10.612

2.  Determinants of vascular function in patients with chronic gout.

Authors:  Robert D Brook; Srilakshmi Yalavarthi; James D Myles; Shokoufeh Khalatbari; Rita Hench; Susan Lustig; Wendy Marder; Adam Neidert; Mariana J Kaplan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-22       Impact factor: 3.738

Review 3.  Allopurinol, uric acid, and oxidative stress in cardiorenal disease.

Authors:  Markus Riegersperger; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

4.  Serum Uric Acid Revealed a U-Shaped Relationship With All-Cause Mortality and Cardiovascular Mortality in High Atherosclerosis Risk Patients: The ASSURE Study.

Authors:  Yan Cang; Shaojie Xu; Jingyin Zhang; Jingyi Ju; Zijun Chen; Keke Wang; Jue Li; Yawei Xu
Journal:  Front Cardiovasc Med       Date:  2021-05-24

5.  Acute ischemic non-embolic stroke and serum level of uric acid.

Authors:  Farhad Iranmanesh; Nazanin Zia Sheykholeslami; Faranak Gadari; Jafar Ahmady
Journal:  Iran J Neurol       Date:  2012

Review 6.  Uric Acid and Arterial Stiffness.

Authors:  Adriana Albu; Ioana Para; Mihai Porojan
Journal:  Ther Clin Risk Manag       Date:  2020-01-28       Impact factor: 2.423

7.  Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia.

Authors:  Kazuomi Kario; Masafumi Nishizawa; Mari Kiuchi; Arihiro Kiyosue; Fumishi Tomita; Hiroshi Ohtani; Yasuhisa Abe; Hideyo Kuga; Satoshi Miyazaki; Takatoshi Kasai; Makiko Hongou; Takanori Yasu; Jin Kuramochi; Yoshihiro Fukumoto; Satoshi Hoshide; Ichiro Hisatome
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-05       Impact factor: 3.738

8.  The Role of Urate in Cardiovascular Risk in Adolescents and Young Adults With Hypertension, Assessed by Pulse Wave Velocity.

Authors:  Mirjam Močnik; Sonja Golob Jančič; Martina Filipič; Nataša Marčun Varda
Journal:  Front Cardiovasc Med       Date:  2022-04-15

9.  Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus.

Authors:  Mirjam Heimhalt-El Hamriti; Corinna Schreiver; Anja Noerenberg; Julia Scheffler; Ulrike Jacoby; Dieter Haffner; Dagmar-C Fischer
Journal:  Cardiovasc Diabetol       Date:  2013-08-12       Impact factor: 9.951

10.  Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Gang Deng; Zhandong Qiu; Dayong Li; Yu Fang; Suming Zhang
Journal:  Med Sci Monit       Date:  2016-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.